FDA Adverse Event Malfunction Summary report: N

ASTRAL 100 - APAC2

MDR report key: 19553650 · Received June 17, 2024

Report

Report Number
3007573469-2024-00167
Event Type
Malfunction
Date Received
June 17, 2024
Date of Event
May 20, 2024
Report Date
June 17, 2024
Manufacturer
RESMED PTY LTD
Product Code
NOU
Product Problem
Yes
Report Source
Distributor report
Reporter Location
KS
Reporter Occupation
505

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE WAS RETURNED TO A THIRD PARTY SERVICE CENTER AND AN EVALUATION CONFIRMED THE COMPLAINT. THE MAIN CIRCUIT BOARD WAS REPLACED TO ADDRESS THE ISSUE. THE DEVICE WAS SERVICED AND FULLY TESTED BEFORE IT WAS RETURNED TO THE CUSTOMER. BASED ON ALL AVAILABLE EVIDENCE AND COMPLAINT INVESTIGATIONS OF A SIMILAR NATURE, AN INVESTIGATION DETERMINED THAT THE REPORTED COMPLAINT WAS DUE TO SUPER CAPACITOR ELECTROLYTE LEAK. RESMED'S RISK ANALYSIS FOR THIS FAILURE MODE CONCLUDES THAT THE RISK IS ACCEPTABLE.RESMED REFERENCE #: PR 3083077

Description of Event or Problem · 0

IT WAS REPORTED TO RESMED THAT AN ASTRAL DEVICE DISPLAYED AN ERROR MESSAGE (SF179) RELATED TO THE SUPER CAPACITOR. THERE WAS NO PATIENT HARM OR SERIOUS INJURY REPORTED AS A RESULT OF THIS INCIDENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2251016 ASTRAL 100 - APAC2 VENTILATOR, CONTINUOUS (FACILITY/HOME) NOU RESMED PTY LTD 27082 1406654

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown